NCT03366610

Study to Assess Clinical Outcomes in Chronic Hepatitis C Patients Previously Treated With Daclatasvir-Based Regimens

A Long Term Off-treatment Follow-Up Study to Assess Clinical Outcomes in Chronic Hepatitis C Patients in China Previously Treated With Daclatasvir-Based Regimens

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 199 (actual)
• Sponsor: Bristol-Myers Squibb · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to assess long-term outcomes in subjects previously treated with daclatasvir-based therapy for chronic Hepatitis-C (CHC)

Conditions

• Hepatitis C

Interventions

Type	Name	Description
OTHER	Non-interventional	Non-interventional

Timeline

• Start date: 2017-04-28
• Primary completion: 2019-04-30
• Completion: 2019-04-30
• First posted: 2017-12-08
• Last updated: 2020-06-18

Locations

1 site across 1 country: China

Regulatory

• FDA-regulated drug study